A barrier system
US-2024051735-A1 · Feb 15, 2024 · US
US10238768B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10238768-B2 |
| Application number | US-201715704673-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 14, 2017 |
| Priority date | Oct 28, 2016 |
| Publication date | Mar 26, 2019 |
| Grant date | Mar 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, a preparation method and use thereof are provided. The sponge comprises squid ink polysaccharide and chitosan as carriers and calcium chloride as an initiator for blood coagulation, and the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan is achieved via a lyophilization technology. Particularly, the preparation method comprises slowly adding a squid ink polysaccharide solution to a chitosan solution to form a uniformly mixed solution, adding a calcium chloride solution to the uniformly mixed solution, forming a gel followed by the gel being frozen and then lyophilized, and achieving the product. The wound-healing and hemostatic sponge has a good absorbing-errhysis effect, a good pro-coagulant effect, fast hemostasis and a complete hemostatic effect, without secondary re-hemorrhage. Moreover, the wound-healing and hemostatic sponge can promote wound healing, re-epithelialization and repair of epidermis and dermis, with strong wound-healing ability, good biocompatibility, weak toxic side effects and irritation, belonging to a novel wound-healing and hemostatic material. Moreover, the preparation method is reliable, fast, and low cost.
Opening claim text (preview).
What is claimed: 1. A preparation method for a wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, comprising steps of: preparing a squid ink polysaccharide and a chitosan as carriers and an initiator for blood coagulation, wherein the initiator for blood coagulation is a calcium chloride solution; dissolving the squid ink polysaccharide in a first solvent to obtain a squid ink polysaccharide solution, and dissolving the chitosan in a second solvent to obtain a chitosan solution; mixing and combining the squid ink polysaccharide solution, the chitosan solution, and the calcium chloride solution; and applying a lyophilization technology to obtain the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, wherein the squid ink polysaccharide solution has a concentration of 0.4 to 0.8 mg/mL. 2. The preparation method according to claim 1 , wherein the steps comprising slowly adding the squid ink polysaccharide solution to the chitosan solution, to form a uniformly mixed solution, adding the calcium chloride solution to the uniformly mixed solution, to obtain a homogenous solution, forming a gel from the homogenous solution, freezing the gel, and applying the lyophilization technology to lyophilize the gel to obtain the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan. 3. The preparation method according to claim 1 , wherein the chitosan solution has a mass concentration of 1.5 to 3.5%, and the calcium chloride solution has a mass concentration of 2 to 6%. 4. The preparation method according to claim 1 , wherein a volume ratio of the squid ink polysaccharide solution, the chitosan solution and the calcium chloride solution is 4-6:13-17:1-3. 5. The preparation method according to claim 1 , wherein the squid ink polysaccharide solution has a concentration of 0.55 mg/mL, the chitosan solution has a mass concentration of 2.29%, the calcium chloride solution has a mass concentration of 2.82%, and a volume ratio of the squid ink polysaccharide solution, the chitosan solution and the calcium chloride solution is 5:15:2. 6. The preparation method according to claim 2 , wherein a condition for the step of freezing the gel is frozen at −30° C. to −10° C. for 10 to 15 hours. 7. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan achieved by the preparation method according to claim 1 . 8. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 7 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly. 9. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, obtained by the preparation method according to claim 2 . 10. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, obtained by the preparation method according to claim 3 . 11. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, obtained by the preparation method according to claim 4 . 12. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, obtained by the preparation method according to claim 5 . 13. A wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan, obtained by the preparation method according to claim 6 . 14. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 9 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly. 15. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 10 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly. 16. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 11 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly. 17. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 12 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly. 18. A method for hemostasis and/or wound healing, comprising applying the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan according to claim 13 onto a wound, compressing the wound until hemostasis is achieved, dressing the wound, and replacing the wound-healing and hemostatic sponge of squid ink polysaccharide/chitosan regularly.
Ingredients of undetermined constitution or reaction products thereof · CPC title
Materials for stopping bleeding · CPC title
Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof · CPC title
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
containing inorganic materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.